Subtherapeutic concentrations of posaconazole tablet: determining risk factors and effectiveness of a standardized dose adjustment in hematology inpatients
Jessica Bui(Royal North Shore Hospital), Julian Lindsay(Royal North Shore Hospital), Rochelle Gellatly(Surrey Memorial Hospital), Jad Othman(The University of Sydney)
Cited by 9
Related Papers
Pretransplant <i>FLT3</i>-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome
|Blood|2022|83
Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study
|Scientific Reports|2021|78
Molecular, clinical, and therapeutic determinants of outcome in <i>NPM1</i>-mutated AML
|Blood|2024|78